IBDEI0PP ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12308,0)
 ;;=611.72^^62^738^56
 ;;^UTILITY(U,$J,358.3,12308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12308,1,3,0)
 ;;=3^611.72
 ;;^UTILITY(U,$J,358.3,12308,1,4,0)
 ;;=4^Lump Or Mass In Breast
 ;;^UTILITY(U,$J,358.3,12308,2)
 ;;=^72018
 ;;^UTILITY(U,$J,358.3,12309,0)
 ;;=625.9^^62^738^72
 ;;^UTILITY(U,$J,358.3,12309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12309,1,3,0)
 ;;=3^625.9
 ;;^UTILITY(U,$J,358.3,12309,1,4,0)
 ;;=4^Pelvic Pain
 ;;^UTILITY(U,$J,358.3,12309,2)
 ;;=^123993
 ;;^UTILITY(U,$J,358.3,12310,0)
 ;;=627.1^^62^738^76
 ;;^UTILITY(U,$J,358.3,12310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12310,1,3,0)
 ;;=3^627.1
 ;;^UTILITY(U,$J,358.3,12310,1,4,0)
 ;;=4^Postmenopausal Bleeding
 ;;^UTILITY(U,$J,358.3,12310,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,12311,0)
 ;;=616.10^^62^738^98
 ;;^UTILITY(U,$J,358.3,12311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12311,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,12311,1,4,0)
 ;;=4^Vaginitis/Vaginal Infection
 ;;^UTILITY(U,$J,358.3,12311,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,12312,0)
 ;;=626.0^^62^738^10
 ;;^UTILITY(U,$J,358.3,12312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12312,1,3,0)
 ;;=3^626.0
 ;;^UTILITY(U,$J,358.3,12312,1,4,0)
 ;;=4^Amenorrhea
 ;;^UTILITY(U,$J,358.3,12312,2)
 ;;=^5871
 ;;^UTILITY(U,$J,358.3,12313,0)
 ;;=783.0^^62^738^11
 ;;^UTILITY(U,$J,358.3,12313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12313,1,3,0)
 ;;=3^783.0
 ;;^UTILITY(U,$J,358.3,12313,1,4,0)
 ;;=4^Anorexia
 ;;^UTILITY(U,$J,358.3,12313,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,12314,0)
 ;;=V76.10^^62^738^18
 ;;^UTILITY(U,$J,358.3,12314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12314,1,3,0)
 ;;=3^V76.10
 ;;^UTILITY(U,$J,358.3,12314,1,4,0)
 ;;=4^Breast Cancer Screening
 ;;^UTILITY(U,$J,358.3,12314,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,12315,0)
 ;;=616.0^^62^738^21
 ;;^UTILITY(U,$J,358.3,12315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12315,1,3,0)
 ;;=3^616.0
 ;;^UTILITY(U,$J,358.3,12315,1,4,0)
 ;;=4^Cervicitis
 ;;^UTILITY(U,$J,358.3,12315,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,12316,0)
 ;;=078.10^^62^738^48
 ;;^UTILITY(U,$J,358.3,12316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12316,1,3,0)
 ;;=3^078.10
 ;;^UTILITY(U,$J,358.3,12316,1,4,0)
 ;;=4^Genital Warts
 ;;^UTILITY(U,$J,358.3,12316,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,12317,0)
 ;;=625.3^^62^738^31
 ;;^UTILITY(U,$J,358.3,12317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12317,1,3,0)
 ;;=3^625.3
 ;;^UTILITY(U,$J,358.3,12317,1,4,0)
 ;;=4^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,12317,2)
 ;;=^37592
 ;;^UTILITY(U,$J,358.3,12318,0)
 ;;=625.0^^62^738^32
 ;;^UTILITY(U,$J,358.3,12318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12318,1,3,0)
 ;;=3^625.0
 ;;^UTILITY(U,$J,358.3,12318,1,4,0)
 ;;=4^Dyspareunia
 ;;^UTILITY(U,$J,358.3,12318,2)
 ;;=^37604
 ;;^UTILITY(U,$J,358.3,12319,0)
 ;;=788.1^^62^738^36
 ;;^UTILITY(U,$J,358.3,12319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12319,1,3,0)
 ;;=3^788.1
 ;;^UTILITY(U,$J,358.3,12319,1,4,0)
 ;;=4^Dysuria
 ;;^UTILITY(U,$J,358.3,12319,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,12320,0)
 ;;=789.30^^62^738^70
 ;;^UTILITY(U,$J,358.3,12320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12320,1,3,0)
 ;;=3^789.30
 ;;^UTILITY(U,$J,358.3,12320,1,4,0)
 ;;=4^Pelvic Abdominal Mass
 ;;^UTILITY(U,$J,358.3,12320,2)
 ;;=^917
 ;;^UTILITY(U,$J,358.3,12321,0)
 ;;=614.9^^62^738^71
 ;;^UTILITY(U,$J,358.3,12321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12321,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,12321,1,4,0)
 ;;=4^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,12321,2)
 ;;=^3537
 ;;
 ;;$END ROU IBDEI0PP
